The effects of DHA/EPA supplementation on atopic dermatitis disease in adult Japanese

Tsuyoshi Takara0 个研究点目标入组 5 人开始时间: 2022年4月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Japanese adults
•2. Men or women
•3. Subjects aged 20 years old or more
•4. Subjects who have been diagnosed with atopic dermatitis
•5. Subjects who are judged as eligible to participate in the study by the physician

•1. Subjectss with moderate or severe atopic dermatitis (skin rash with severe inflammation*)
•*Lesions with erythema, papules, erosions, infiltrates, lichenification, etc.
•2. Subjects have allergy to milk
•3. Subjects who are aspirin hypersensitivity or who are regular users of drugs containing aspirin
•4. Subjects who consume bluefish such as sardines, mackerel, and saury at least 4 days per week.
•5. Subjects who are pregnant, breast-feeding, and planning to become pregnant
•6. Subjects who suffering from COVID-19
•7. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial
•8. Subjects who are judged as ineligible to participate in the study by the physician

发起方

Tsuyoshi Takara